drugset / Trial / NCT02029040

Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis

NCT02029040 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, controlled trial in the Pediatric Emergency Department. The primary objective is to determine whether nebulized 3% hypertonic saline is more effective than nebulized 0.9% saline in the treatment of bronchiolitis in the emergency department.

Timeline

Start
2013-12
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 3% hypertonic saline Unknown 3 % Inhaled

Indications